Background Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
condition that is associated with severe disability. Approximately 40% of individuals are …

Background and Purpose The detection of aquaporin 4-IgG (AQP4-IgG) is now a critical
diagnostic criterion for neuromyelitis optica spectrum disorder (NMOSD). To evaluate the …

Abstract Background The 2015 International Panel for Neuromyelitis Optica (NMO)
Diagnosis (IPND) criteria was revised using systematic literature reviews and consensus …

The distinction between criteria types is also relevant to MS and NMOSD. Although
classification criteria are appropriate for MS because a single standard is lacking, AQP4-IgG …

Objective: To evaluate the application of the 2015 International Panel for NMO Diagnosis
(IPND) criteria to consecutive cases of neuromyelitis optica spectrum disorder (NMOSD) in a …

Background Diagnosis of neuromyelitis optica spectrum disorders (NMOSD) in India is
hindered by limited access to cost effective and sensitive assays for detection of aquaporin-4 …

Background Comorbidity may influence clinical aspects of neuromyelitis optica spectrum
disorder (NMOSD). We estimated the prevalence of comorbidities to assess their association …

Importance Immunoglobulin G autoantibodies for aquaporin 4 (AQP4-IgG) serve as
diagnostic biomarkers for neuromyelitis optica spectrum disorder (NMOSD), and the most …

Objective: To revise diagnostic criteria for neuromyelitis optica (NMO) and NMO spectrum
disorders. Background: NMO is an inflammatory demyelinating CNS syndrome distinct from …

Background: The international panel for neuromyelitis optica (NMO) diagnosis has proposed
diagnostic criteria for neuromyelitis optica spectrum disorders (NMOSD). Objectives: We …